Glycogen storage disease type II secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of glycogen storage disease type 2 (GSD type 2) include general medical recommendations, [[cardiology]] recommendations, [[pulmonary]] recommendations, [[gastrointestinal]]/[[nutritional]] recommendations, [[musculoskeletal]]/functional/rehabilitation recommendations, [[neurological]] recommendations., and surgery/anesthesia recommendations | Effective measures for the secondary prevention of glycogen storage disease type 2 (GSD type 2) include general medical recommendations, [[cardiology]] recommendations, [[pulmonary]] recommendations, [[gastrointestinal]]/[[nutritional]] recommendations, [[musculoskeletal]]/functional/rehabilitation recommendations, [[neurological]] recommendations., and [[surgery]]/[[anesthesia]] recommendations. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Line 123: | Line 123: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Revision as of 19:40, 23 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II secondary prevention On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II secondary prevention |
FDA on Glycogen storage disease type II secondary prevention |
CDC on Glycogen storage disease type II secondary prevention |
Glycogen storage disease type II secondary prevention in the news |
Blogs on Glycogen storage disease type II secondary prevention |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Effective measures for the secondary prevention of glycogen storage disease type 2 (GSD type 2) include general medical recommendations, cardiology recommendations, pulmonary recommendations, gastrointestinal/nutritional recommendations, musculoskeletal/functional/rehabilitation recommendations, neurological recommendations., and surgery/anesthesia recommendations.
Secondary Prevention
- Effective measures for the secondary prevention of glycogen storage disease type 2 (GSD type 2) include:[1]
- General medical care recommendations
- Cardiology recommendations
- Pulmonary recommendations
- Gastrointestinal/nutritional recommandations
- Musculoskeletal/functional/rehabilitation recommendation
- Neurological recommendations
- Surgery/anesthesia recommendations
General medical care recommendations |
|
Adopted from Genetics in Medicine |
Cardiology recommendations |
|
Adopted from Genetics in Medicine |
Pulmonary recommendations |
|
Adopted from Genetics in Medicine |
Gastrointestinal/nutritional recommandations |
|
Adopted from Genetics in Medicine |
Musculoskeletal/functional/rehabilitation recommendation |
|
Adopted from Genetics in Medicine |
Neurological recommendations |
|
Adopted from Genetics in Medicine |
Surgery/Anesthesia recommendations |
|
Adopted from Genetics in Medicine |
References
- ↑ ACMG Work Group on Management of Pompe Disease. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ; et al. (2006). "Pompe disease diagnosis and management guideline". Genet Med. 8 (5): 267–88. doi:10.109701.gim.0000218152.87434.f3 Check
|doi=
value (help). PMC 3110959. PMID 16702877.